Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)30848-2
Abstract: Baseline kidney function appeared to modify the effects of the SGLT2 inhibitor canagliflozin compared to placebo on stroke in the CANVAS Program. We extracted data from the EMPA-REG OUTCOME, DECLARE-TIMI 58 and CREDENCE trials to…
read more here.
Keywords:
baseline kidney;
kidney function;
effects sglt2;
Sign Up to like & get
recommendations!
0
Published in 2019 at "Current topics in medicinal chemistry"
DOI: 10.2174/1568026619666190828161409
Abstract: Type 2 diabetes mellitus is one of the most common form of the disease worldwide. Hyperglycemia and insulin resistance play key roles in type 2 diabetes mellitus. Renal glucose reabsorption is an essential feature in…
read more here.
Keywords:
sglt2 inhibitors;
renal dysfunction;
disease;
type diabetes ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11050982
Abstract: Clinical trials have shown that sodium glucose co-transporter 2 (SGLT2) inhibitors improve clinical outcomes in diabetes mellitus (DM) patients. As most studies were performed in Type 2 DM, the cardiovascular effects of SGLT2 inhibition still…
read more here.
Keywords:
effects sglt2;
dapa;
sglt2 inhibition;
model type ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22063062
Abstract: Sodium-glucose co-transporter 2 (SGLT2) inhibitors facilitate urine glucose excretion by reducing glucose reabsorption, leading to ameliorate glycemic control. While the main characteristics of type 2 diabetes mellitus are insufficient insulin secretion and insulin resistance, SGLT2…
read more here.
Keywords:
sglt2 inhibitors;
insulin;
inhibitors pearls;
pleiotropic effects ... See more keywords